Drug: CELLCEPT Injury: Pulmonary fibrosis Quarter: 2016Q3
Total Records: 6 Number of Pages: 1
| Event ID | DRUGNAME | PT | Drug Manufacturer | Patient Age | Sex | Weight | Date (YYYYMMDD) | Country |
|---|---|---|---|---|---|---|---|---|
| 125068223 | CELLCEPT | Pulmonary fibrosis | ROCHE | 0.00 | F | 50 KG | 20160726 | US |
| 125267031 | CELLCEPT | Pulmonary fibrosis | ASTELLAS | 65.59 YR | M | 0 | 20160705 | FR |
| 125286221 | CELLCEPT | Pulmonary fibrosis | NOVO NORDISK | 71.00 YR | M | 0 | 20160705 | FR |
| 125289401 | CELLCEPT | Pulmonary fibrosis | AVENTIS | 71.00 YR | M | 0 | 20160705 | FR |
| 125485781 | CELLCEPT | Pulmonary fibrosis | APOTEX | 71.00 YR | M | 0 | 20160712 | GB |
| 125498941 | CELLCEPT | Pulmonary fibrosis | ASTRAZENECA | 862.00 MON | M | 0 | 20160712 | FR |
Total Records: 6 Number of Pages: 1